Inspire(US:INSP) Globenewswire·2026-01-05 14:01Core Viewpoint - A securities class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) for allegedly misleading investors about operational failures related to the launch of its Inspire V device for obstructive sleep apnea [1][3]. Summary by Relevant Sections Lawsuit Details - The lawsuit is pending in the U.S. District Court for the District of Minnesota and targets investors who purchased INSP securities between August 6, 2024, and August 4, 2025 [2][3]. - The Lead Plaintiff Deadline is set for January 5, 2026, urging affected investors to contact legal representatives [3]. Allegations of Misleading Information - Inspire Medical allegedly assured investors of its "operational readiness" for the Inspire V launch, claiming it was ready for a full commercial rollout, which the lawsuit argues concealed significant operational failures [3][4]. - The undisclosed operational issues included: - Medicare & Billing Readiness: Necessary software updates for Medicare claims processing were not effective until July 1, 2025, preventing implanting centers from billing for procedures, which stalled early adoption and revenue generation [4]. - Excess Inventory: A significant surplus of the older Inspire IV device impacted demand for the new Inspire V, leading to a need for inventory reduction [4]. - Training & Onboarding: Many treatment centers had not completed essential training for the new device, contributing to operational delays [4]. Impact on Business and Stock - The alleged operational failures resulted in a drastic cut to Inspire's 2025 earnings per share (EPS) guidance by over 80%, leading to a stock price drop of $42.04 per share, equating to a 32.4% decline in value [4]. Investigation Focus - Hagens Berman's investigation emphasizes the concealment of critical issues, particularly the Medicare claims software failure and the inventory glut of the prior device, suggesting that management prioritized a narrative of seamless transition over operational reality [5]. Legal Options for Investors - Investors who purchased INSP securities during the class period may have legal options and are encouraged to contact Hagens Berman for further information [5].